European Archives - Page 766 of 1303 - European Medical Journal

EMJ Podcast: Benefits of Neoadjuvant use of Mitomycin C for the Management of NMIBC

This episode, sponsored by medac, is a discussion around non-muscle-invasive bladder cancer (NMIBC). We hear from Professor Jørgen Bjerggaard Jensen as he explores the management of NMIBC through the neoadjuvant use of Mitomycin C (MMC).

EMJ Nephrology 9 [Supplement 1] 2021 Feature Image

EMJ Nephrology 9 [Supplement 1] 2021

In this supplement to EMJ Nephrology, two leading nephrologists, Patrice Ambühl and Jordi Bover, discussed the burden and management…

EMJ Podcast: Emerging Treatments in Atopic Dermatitis

This episode is the fourth installment in a five-part series exploring the treatments in atopic dermatitis (AD).

Talking to Florent Edouard

Florent Edouard, ‎Senior Vice President, Global Head of Commercial Excellence, Grünenthal Group, talks about AI in digital transformation.

Can a Baby’s First Stool Predict the Risk of Developing Allergies?

This predicted, with a high degree (76%) of accuracy and more reliably than ever before, whether an infant would develop allergies by 1 year of age…

COVID-19 Vaccination in Individuals with High-Risk Allergy Histories

However, severe allergic reactions created a potential barrier to large-scale vaccination rollout. For this reason, academics at Massachusetts General…

Oxy-hydrogen Gas: The Rationale Behind Its Use as a Novel and Sustainable Treatment for COVID-19 and Other Respiratory Diseases

During both acute and chronic respiratory conditions, including severe coronavirus disease (COVID-19) infection, the primary physiological response is to synthesise distress proteins, which include cytokines, chemokines, and growth factors…

EMJ Podcast: Spotting Pseudoscience

We reflect on the well-being industry, considering what it gets right, where it goes wrong and offers tips on how to spot themes of pseudoscience.

A Prescription of Aerobic Exercise for Rheumatic Disorders

EXERCISE reduces the risk of cardiovascular disease in those with rheumatic disorders. Individuals with autoimmune rheumatic diseases (ARDs), such as rheumatoid arthritis and lupus, are more likely to develop atherosclerosis and are thereby at a higher risk of a heart attack and other cardiovascular disorders.

A Safer Strategy for Steroid Use in Patients with Lupus

LUPUS could now be treated with a lower dose of steroids, lessening the side effects experienced by patients and improving their health long-term. The research was published by Eric Morand and the Rheumatology Group at Monash University, Melbourne, Australia, who aimed to gain insight into ways of tracking patient exposure to steroids.